BM
Brandywine Managers Portfolio holdings
AUM
$104M
1-Year Est. Return
28.94%
1 Year Est. Return
+28.94%
AUM
$101M
AUM Growth
+$17.3M
(+21%)
Holding
36
Top Buys
| 1 | +$214K | |
| 2 | +$146K | |
| 3 | +$130K | |
| 4 |
Beam Therapeutics
BEAM
|
+$124K |
Top Sells
| 1 | +$155K | |
| 2 | +$144K | |
| 3 | +$114K | |
| 4 |
Okta
OKTA
|
+$80K |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$42.4K |
Sector Composition
| 1 | Technology | 50.63% |
| 2 | Healthcare | 10.84% |
| 3 | Financials | 1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Schrodinger
SDGR
$1.31B
| $420K | 0.42% |
20,886
|
|
||
|
27
Beam Therapeutics
BEAM
$2.71B
| $316K | 0.31% |
18,606
+7,300
|
|
||
28
Twilio
TWLO
$19.4B
| $293K | 0.29% |
2,357
|
|
||
29
Moderna
MRNA
$9.84B
| $262K | 0.26% |
9,510
|
|
||
30
Novo Nordisk
NVO
$211B
| $259K | 0.26% |
3,747
-475
|
|
||
31
Structure Therapeutics
GPCR
$1.92B
| $229K | 0.23% |
11,057
|
|
||
32
10x Genomics
TXG
$2.26B
| $219K | 0.22% |
18,938
|
|
||
33
Viking Therapeutics
VKTX
$4B
| $214K | 0.21% |
+8,082
|
|
||
34
SentinelOne
S
$5.68B
| $192K | 0.19% |
10,501
-8,500
|
|
||
35
Relay Therapeutics
RLAY
$1.36B
| $133K | 0.13% |
38,429
|
|
||
36
AbCellera Biologics
ABCL
$1.04B
| $97.7K | 0.1% |
28,488
|
|